REPLY
13.9.2021 11:32:12 CEST | Business Wire | Press release
Following the success of the first edition and the satisfaction shown by all the students who participated in the training path, and now in working in corporate projects, Reply and the Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino announce that enrolment is now open for the second edition of the second-level Master's degree course in "Artificial Intelligence & Cloud Hands-on innovation" .
Starting in January 2022 , the Master’s offers 40 highly qualified students a professional specialisation path in the IT sector through its most innovative technologies: artificial intelligence, machine learning and cloud .
The lessons will be held in person at the Politecnico di Torino and will combine Politecnico di Torino professors and Reply specialists in a mix of theoretical lessons and practical live cases . During the programme, students will work in groups on live projects at Reply , where they will put into practice the knowledge acquired in the classroom.
The Master's is open to students who have previously obtained a Master's degree in either Computer Science, Computer Engineering, Automation Engineering, Telecommunications Engineering, Electronic Engineering and Cybersecurity (the degree must be completed by December 31, 2021). The entire course is in English and it is open to international entrants.
Applications should be submitted online by October 22, 2021 following the instructions available at master.reply.com . This will be followed by an evaluation process in which a commission made up of members of the Politecnico di Torino and Reply professionals will assess the candidates' curricula, educational background and professional experience. The commission will also meet each candidate for an individual interview.
The “Earn While You Learn” formula has also been confirmed for this second edition. Reply commits to hire the selected candidates right from the start of the programme and to bear all the costs of participation in the Master’s for those who accept the job offer.
“Through this specialisation path, in collaboration with the Politecnico di Torino, we aim to create an elite group of students who are highly qualified in the most innovative IT issues and to progressively include these students in our projects” explains Filippo Rizzante, Reply CTO. “Artificial intelligence, machine learning and cloud are fundamental for Reply and for our customers, which is why we want to train students in these technologies right from the start.”
"The Master’s in collaboration with Reply – explains the Specializing Master's Programmes and Lifelong Learning School’s Director, Prof. Paolo Neirotti – is one of the initiatives of excellence that the Master’s School designs and delivers. The programme has a custom-made approach for sector leaders and confirms that the digital transformation requires the various profiles coming out of Master's degrees in Engineering to have hyper-technical specialisation. As a technical university, we are well prepared to provide this specialisation as we design Master's programmes that integrate, recombine and extend the different scientific areas within our second-level training offer. On top of this we also rely on our experience in company applied research and technology."
Politecnico di Torino is recognized as one of the most respected universities in Europe and Reply is a company that has made innovation and technological specialization its flagship. Both entities have joined forces to create a training path for excellence; one aimed at preparing the professionals the industry needs to face the challenges of the future.
More information available at master.reply.com and https://didattica.polito.it/master/ai_cloud/2022/at_a_glance .
°°°
REPLY
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino
The Specializing Master's Programmes and Lifelong Learning School of the Politecnico di Torino was founded in December 2011 with the aim of organising and managing first-level and second-level Master’s programmes, as well as Lifelong Learning courses, including executive courses. The School stands out for the variety and multidisciplinary nature of its Master’s programmes and training courses, which are an expression of the many scientific and cultural areas present within a research university such as the Politecnico di Torino. The training offer proposed by the School covers several disciplinary areas in order to provide support to companies and public and private institutions, so that they develop their transition ability towards new technological, economic and social paradigms (e.g. electrification, sustainability, digital transformation). Consistent with the polytechnic tradition, the scientific areas underpinning the School's continuing education offer are related to Industry 4.0, new forms of mobility, development and technology transfer in aerospace, digital transformation of businesses, public administration and society, environmental and energy sustainability, digitalisation in construction, new approaches and new frontiers in design, and the design of territories in the perspective of resilience.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210913005045/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Industrial Decarbonization: Calderion, WenCo and Terravent Invest in Graforce to Scale Plasma Pyrolysis Globally25.2.2026 08:07:00 CET | Press release
The investor consortium comprising the Paris-based Next Generation Fuels Industrial & Technological fund Calderion (Audacia), alongside infrastructure developer Terravent and WenCo Family Office, announces the closing of a strategic double-digit million-euro financing round for Berlin-based Graforce GmbH. The investment is dedicated to the industrial scale-up of Graforce’s proprietary plasma pyrolysis technology, addressing the growing global demand for cost-efficient low-carbon hydrogen, syngas, and carbon removal solutions that are compatible with existing industrial infrastructures. Disruptive alternative to conventional processes Graforce’s technology aims at replacing CO₂-intensive legacy routes such as steam reforming and classical gasification. By applying plasma to methane, biogas, flare gas, and landfill gas, the process converts these streams into their valuable molecular components instead of emitting them. The result is a high-efficiency production of clean hydrogen and syn
Mevion Medical Systems Announces CE Marking of the MEVION S250-FIT™ Proton Therapy System, Expanding Global Access to Compact Proton Therapy25.2.2026 08:00:00 CET | Press release
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems, the global leader in compact proton therapy, today announced that the MEVION S250-FIT Proton Therapy System has successfully completed the conformity assessment process and has received CE Marking under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone enables the marketing, sale, and clinical use of the MEVION S250-FIT system throughout the European Union, building on the system’s existing U.S. FDA 510(k) clearance granted in September 2025. The MEVION S250-FIT is the first and only proton therapy system designed to fit into a standard radiation therapy vault. By enabling cancer centers to use their existing infrastructure, the MEVION S250-FIT dramatically reduces the cost, complexity, and timeline traditionally associated with proton therapy adoption. This opens a new pathway for hospitals and cancer centers a
Bureau Veritas:Sector-Leading Organic Revenue Growth of 6.5% in FY 202525.2.2026 07:30:00 CET | Press release
Strong margin improvement to 16.3% in FY 2025Positive growth outlook with continued margin expansion in 2026New EUR 200 million share buyback Bureau Veritas (BOURSE:BVI): 2025 key figures1 › Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted operating profit of EUR 1,052.9 million, up 5.7% versus EUR 996.2 million in FY 2024, representing an adjusted operating margin of 16.3%, up 32 basis points year-on-year and up 51 basis points at constant currency, › Operating profit of EUR 992.4 million, up 6.3% versus EUR 933.4 million in FY 2024, › Adjusted net profit of EUR 631.4 million, up 1.7% versus EUR 620.7 million in FY 2024, › Adjusted EPS stood at EUR 1.42 in 2025, with a 2.8% increase versus FY 2024 (EUR 1.38 per share) and up 9.2% at constant currency, › Attributable net profit of EUR 588.0 million, up 3.3% versus EUR 569.4 million in FY 2
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom